NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What is a significant risk when using Anastrozole or Letrozole, compared to SERMs?

Lower risk of osteoporosis
Higher risk of osteoporosis
Lower risk of cardiovascular disease
No risk of thromboembolic events

The correct answer is: Higher risk of osteoporosis

When using Anastrozole or Letrozole, compared to SERMs, there is a higher risk of osteoporosis because these drugs, known as aromatase inhibitors, decrease estrogen levels in the body which can result in bone loss. SERMs, on the other hand, have been shown to have a protective effect on bone health. The other options are incorrect because they do not address the potential side effects of Anastrozole and Letrozole. While these drugs may have lower risks of cardiovascular disease and no risk of thromboembolic events, those benefits do not apply to the increased risk of osteoporosis.